Follow the Newron Pharmaceuticals S.p.A. share price and the full directors' dealings record of the company, a publicly traded company based in Switzerland. Shares are listed on CH CH, under the oversight of SIX SER. Operating in the Health Care sector, Newron Pharmaceuticals S.p.A. has published 9 insider filings. Market capitalisation: €295m. The latest transaction was reported on 2 December 2025 (Sale). Among the most active insiders: Anonymous (Non-executive member of the board of directors). All data is free.
9
Insider Decl.
0
Thresholds
€165,186
6 ops.
Buy Volume
€487,256
3 ops.
Sell Volume
24Σ signal
Buys €165,186€487,256 Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 2 December 2025
Declarations9 total
●
Anonymous (Non-executive member of the board of directors)
Non-executive member of the board of directors·Executives·